SPOTEX- erythromycin gel
Pella Pharmaceuticals Co. Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.


Each 1 g contains: Erythromycin base 40 mg.
Excipients: Ethanol 99.9%, Hydroxypropyl cellulose, Butylated hydroxytoluene.


Erythromycin which belongs to a class of chemicals called macrolide antibiotics; exerts its antibacterial action by binding to the 50S ribosomal subunit of susceptible bacteria and suppressing protein synthesis. Erythromycin is usually bacteriostatic but may be bactericidal in high concentrations or against highly susceptible organisms.


Spotex is indicated for the treatment of Acne Vulgaris, Acne appears as blackheads and whiteheads which people often refer to as pimples or spots. Spotex attacks the bacteria that are one of the main causes of acne. The name of these bacteria is Propionibacterium acnes


Spotex is contraindicated if you are allergic (hypersensitive) to Erythromycin or any of the other ingredients of Spotex.
An allergic reaction may include a rash or itching.


If you use Spotex on your face don t get it in your eyes, nose/nostrils, mouth, or on your lips. If you do, wash the area with large amount of warm water. And do not use Spotex on areas where you have cuts or scrapes.
Excessive exposure to sunlight or ultraviolet rays ( sun lamps) should be avoided during treatment with Spotex because the additional irradiation may lead to a more intense action.
If sunburn occurs, it is advisable to interrupt therapy until the severe erythema and peeling subside. Patients whose occupations require considerable exposure to the sun should exercise particular caution.


Ask your doctor or pharmacist for advice before taking any medicine.


Do not apply Spotex on your chest if you are breast feeding.
Ask your doctor or pharmacist for advice before taking any medicine.

Drug Interactions

Do not use Spotex with any other acne products that are used on the skin unless your doctor or pharmacist has told you that you can.
While you are using Spotex , do not use skin cleansers that remove dead skin (these are called exfoliants), medicated soaps or cosmetics containing alcohol. These could make your skin irritated or dry.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.


Topical gels and creams are intended for external use only and should be kept away from eyes, nose, mouth, and other mucous membranes because of its irritant effect. Do not apply to eyelids or to the skin at the corners of the eyes and mouth. Avoid the angles of the nose and nasolabial fold (if treatment in these areas; is necessary, apply very sparingly). Topical use may induce severe local erythema and peeling at the site of application. If the degree of local irritation warrants, patients should be directed to use the medication less frequently, discontinue use temporarily or discontinue use altogether.

Dosage and Administration

Use Spotex once in the morning and once in the evening, unless your doctor or pharmacist has told you otherwise.
Wash the affected areas with water or with a mild cleanser, and then thoroughly dry the affected areas and gently apply on a thin film of Spotex using the tips of your fingers. Don’t forget to wash your hands afterwards.

The alcohol quickly evaporates and erythrornycin penetrates into your skin without leaving an unpleasant film, after you have used Spotex ; screw the cap tightly on the tube.

How long you will have to use Spotex will depend on how quickly your acne improves. You may well use Spotex Gel for one month and then a lower strength product for one more month. Your doctor will decide which strength to prescribe for you.
It is recommended to use sunscreens over treated areas before sun exposure.


Do not put too much Spotex on your skin. You will not get rid of the acne any quicker. If you put on too much, your skin may become irritated and red. Some peeling or discomfort could also occur. If any of these happen, use Spotex once a day in the evening until they have gone. Then apply Spotex twice a day as you did previously. If the effects continue or are causing you a lot of discomfort, stop using the product and ask your doctor or pharmacist for advice.
In the rare event that you accidentally swallow any of this product, seek medical advice.

Side Effects

Like all medicines Spotex can cause side effects, although not everybody gets them. These might include dryness, itching, redness, peeling or oiliness. You might feel a stinging or burning sensation when you put it on your skin. Usually the effects are not serious and happen at the start of treatment. More often than not, they go away as you continue to use the gel.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


Store below 25 °C.

How supplied

30 g packs.


  • Medicament is a product which affects your health and its consumption contrary to instructions is dangerous for you.
  • Strictly follow the doctor’s prescription, the method of use and the instruction of the pharmacist who sold the medicament.
  • The doctor and the pharmacist are experts in medicine, its benefits and risks.
  • Do not by yourself interrupt the period of treatment prescribed for you.
  • Do not repeat the same prescription without consulting your doctor.
  • Keep medicament out of reach of children

Primary Package

Primary Package
(click image for full-size original)

Secondary Package

Secondary Package
(click image for full-size original)

erythromycin gel
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:82160-126
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
# Item Code Package Description Multilevel Packaging
1 NDC:82160-126-01 1 TUBE in 1 CARTON contains a TUBE
1 30 g in 1 TUBE This package is contained within the CARTON (82160-126-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 09/10/2013
Labeler — Pella Pharmaceuticals Co. Ltd (562370925)

Revised: 01/2023 Pella Pharmaceuticals Co. Ltd

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.